Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Predictive Value of Obesity and Lipid Related Variables for Metabolic Syndrome and Insulin Resistance in Obese Adults

  • Shin, Kyung A (Department of Clinical Laboratory Science, Shinsung University)
  • Received : 2019.06.05
  • Accepted : 2019.07.24
  • Published : 2019.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, obese adults were compared for their ability to predict obesity and lipid related variables and their optimal cutoff values to predict metabolic syndrome and insulin resistance. In this study, 9,256 adults aged 20 years or older and less than 80 years old, who were in the Gyeonggi region from January 2014 to December 2016 and who were examined at a general hospital, were enrolled. The diagnostic criteria for obesity were WHO (World Health Organization), and BMI $25kg/m^2$ or more presented in the Asia-Pacific region. Metabolic syndrome was diagnosed based on the criteria of American Heart Association / National Heart, Lung, and Blood Institute (AHA / NHLBI). According to the results of receiver operating characteristic curve (ROC) analysis, Triglyceride / HDL-cholesterol (TG / HDL-C), Triglyceride and Glucose (TyG) index, lipid accumulation product (LAP) and visceral adiposity index (VAI) showed high predictive power for diagnosing metabolic syndrome. The diagnostic accuracy of LAP (AUC: 0.854) for males and VAI (0.888) for females was the highest. The optimal cutoff value of LAP was 42.71 for male and 35.44 for female, and the cutoff value of VAI was 1.92 for male and 2.15 for female. In addition, WHtR (waist to height ratio), TyG index, and LAP were used as predictors of insulin resistance in obese adults. Therefore, LAP and VAI were superior to other indicators in predicting metabolic syndrome in obese adults.

Keywords

References

  1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009. 120: 1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
  2. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010. 33: 920-922. https://doi.org/10.2337/dc09-1825
  3. Arsenault BJ, Boekholdt SM, Kastelein JJ. Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol. 2011. 8: 197-206. https://doi.org/10.1038/nrcardio.2010.223
  4. Chu SY, Jung JH, Park MJ, Kim SH. Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/highdensity lipoprotein cholesterol ratio. Ann Pediatr Endocrinol Metab. 2019. 24: 41-48. https://doi.org/10.6065/apem.2019.24.1.41
  5. Cordero A, Laclaustra M, Leon M, Casasnovas JA, Grima A, Luengo E, et al. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am J Cardiol. 2008. 102: 424-428. https://doi.org/10.1016/j.amjcard.2008.03.079
  6. Elahi D. In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care. 1996. 19: 278-286. https://doi.org/10.2337/diacare.19.3.278
  7. Eliasson B, Cederholm J, Eeg-Olofsson K, Svensson AM, Zethelius B, Gudbjornsdottir S. Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register. Diabetes Care. 2011. 34: 2095-2100. https://doi.org/10.2337/dc11-0209
  8. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014.105: 141-150. https://doi.org/10.1016/j.diabres.2014.04.006
  9. Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008. 31: 1898-1904. https://doi.org/10.2337/dc08-0423
  10. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006. 119:812-819. https://doi.org/10.1016/j.amjmed.2006.02.031
  11. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997. 96: 2520-2525. https://doi.org/10.1161/01.CIR.96.8.2520
  12. Gill T. Epidemiology and health impact of obesity: an Asia Pacific perspective. Asia Pac J Clin Nutr. 2006. 15: 3-14.
  13. Goldani H, Adami FS, Antunes MT, Rosa LH, Fassina P, Quevedo Grave MT, et al. Applicatility of the visceral adiposity index (VAI) in the prediction of the components of the metabolic syndrome in elderly. Nutr Hosp. 2015. 32: 1609-1615.
  14. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005. 112: 2735-2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  15. Gu Z, Zhu P, Wang Q, He H, Xu J, Zhang L, et al. Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population. Lipids Health Dis. 2018. 17: 289. https://doi.org/10.1186/s12944-018-0927-x
  16. Guo SX, Zhang XH, Zhang JY, He J, Yan YZ, Ma JL, et al. Visceral Adiposity and Anthropometric Indicators as Screening Tools of Metabolic Syndrome among Low Income Rural Adults in Xinjiang. Sci Rep. 2016. 6: 36091. https://doi.org/10.1038/srep36091
  17. Haslam DW, James WP. Obesity. Lancet. 2005. 366: 1197-1209. https://doi.org/10.1016/S0140-6736(05)67483-1
  18. Hsueh WA, Quinones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003. 92: 10J-17J.
  19. Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005. 5: 26. https://doi.org/10.1186/1471-2261-5-26
  20. Korea Ministry of Health and Welfare. Korean national health and nutrition examination survey '07-'10 [Internet]. Sejong: Ministry of Health and Welfare; 2012 [cited 2019 May 13]. Available from: http://webcache.googleusercontent.com/search?q=cache:pHqT6158rPAJ:www.mohw.go.kr/react/modules/download.jsp%3FBOARD_ID%3D140%26CONT_SEQ%3D268137%26FILE_SEQ%3D102553+&cd=1&hl=ko&ct=clnk&gl=kr
  21. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci. 2006. 21: 695-700. https://doi.org/10.3346/jkms.2006.21.4.695
  22. Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS One. 2014. 9: e90430. https://doi.org/10.1371/journal.pone.0090430
  23. Li R, Li Q, Cui M, Yin Z, Li L, Zhong T, et al. Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese. J Diabetes Investig. 2018. 9: 411-418. https://doi.org/10.1111/jdi.12708
  24. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005. 96: 399-404. https://doi.org/10.1016/j.amjcard.2005.03.085
  25. Namazi Shabestari A, Asadi M, Jouyandeh Z, Qorbani M, Kelishadi R. Association of Lipid Accumulation Product with Cardio-Metabolic Risk Factors in Postmenopausal Women. Acta Med Iran. 2016. 54: 370-375.
  26. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord. 2003. 27: S6-11. https://doi.org/10.1038/sj.ijo.0802491
  27. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994. 73: 460-468. https://doi.org/10.1016/0002-9149(94)90676-9
  28. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988. 37: 1595-1607. https://doi.org/10.2337/diab.37.12.1595
  29. Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016. 46: 189-197. https://doi.org/10.1111/eci.12583
  30. Shin KA. Triglyceride and glucose (TyG) index is a clinical surrogate marker for the diagnosis of metabolic syndrome. Biomedical Science Letters. 2017. 23: 348-354. https://doi.org/10.15616/BSL.2017.23.4.348
  31. Shin KA. Assessing a body shape index and waist to height ratio as a risk predictor for insulin resistance and metabolic syndrome among Korean adults. Korean J Clin Lab Sci. 2018a. 50: 44-53. https://doi.org/10.15324/kjcls.2018.50.1.44
  32. Shin KA. Significance of non HDL-cholesterol and triglyceride to HDL-cholesterol ratio as predictors for metabolic syndrome among Korean elderly. Korean J Clin Lab Sci. 2018b. 5: 245-252.
  33. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008. 6: 299-304. https://doi.org/10.1089/met.2008.0034
  34. Taverna MJ, Martinez-Larrad MT, Frechtel GD, Serrano-Rios M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011. 164:559-567. https://doi.org/10.1530/EJE-10-1039
  35. Wang F, Wu S, Song Y, Tang X, Marshall R, Liang M, et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr Metab Cardiovasc Dis. 2009. 19: 542-547. https://doi.org/10.1016/j.numecd.2008.11.006
  36. World Health Organization. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney, Australia: health communications Australia; 2000. p19-20.
  37. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004. 363: 157-163. https://doi.org/10.1016/S0140-6736(03)15268-3
  38. Yang H, Xin Z, Feng JP, Yang JK. Waist-to-height ratio is better than body mass index and waist circumference as a screening criterion for metabolic syndrome in Han Chinese adults. Medicine (Baltimore). 2017. 96: e8192. https://doi.org/10.1097/MD.0000000000008192
  39. Zhang L, Yuan Z, Chen W, Chen S, Liu X, Liang Y, et al. Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population. Int J Environ Res Public Health. 2014. 11:7622-7635. https://doi.org/10.3390/ijerph110807622